If you are a current Jazz employee please apply via the Internal Career site.

Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visitwww.jazzpharmaceuticals.comfor more information.

The Breast Cancer / Pan Tumor Medical Director (MD) will, in partnership with the Global Medical Affairs Lead, co lead the development and execution of strategic medical plans for this molecule across breast cancer and broader pan tumor indications. The role will drive the implementation of global and regional medical affairs activities aligned with the overarching strategy. Deep medical affairs expertise and strong clinical knowledge in oncology are essential, with a preference for experience in breast cancer, HER2 expressing tumors, or targeted therapies.

As a key member of the Global Medical and Scientific Affairs (GMSA) organization, the MD will report directly to the Therapy Area Head, Oncology. The successful candidate will co create and lead annual and long range Global Medical Plans, including integrated evidence generation strategies, ensuring alignment with Franchise and Global Product Team (GPT) objectives.
This individual will demonstrate leadership within a fast paced, high performing medical team, foster cross functional collaboration, and communicate effectively across global and regional stakeholders. The role requires strong partnerships with Medical Affairs, Clinical Development, Commercial, Regulatory, and Market Access teams, as well as influential engagement with external experts in breast cancer and other relevant tumour types.

Key Responsibilities

Co‑lead the development and execution of annual and long‑range Global Medical Plans and evidence generation strategies for the assigned molecule in breast cancer and pan‑tumour settings.
Drive global and regional medical affairs strategies, ensuring actionable insights inform robust, cross‑functional plans.
Actively influence the Medical Functional Matrix Team (FMT) for the molecule and lead team meetings when delegated.
In collaboration with the GMAL, oversee protocol and study design development, ensuring scientific rigor and strategic alignment across tumour types.
Build impactful scientific platforms and narratives that shape disease‑area and product positioning in breast cancer and broader HER2‑expressing malignancies.
Co‑direct global medical communications strategy and publication planning, ensuring timely, high‑quality scientific deliverables.
Provide strategic guidance for core materials (e.g., training decks, scientific platforms, study summaries) for global and regional dissemination.
Partner with Commercial to co‑lead launch readiness and lifecycle management initiatives across multiple tumour indications.
Represent Global Medical Affairs at cross‑functional team meetings and external scientific or medical engagements.
Maintain deep subject‑matter expertise in breast cancer and pan‑tumour HER2 biology, anticipating disease‑area evolution through competitive intelligence and insights generation.
Build and maintain external stakeholder engagement plans, including expert mapping, advisory boards, and collaborative opportunities with key opinion leaders.
Champion patient advocacy initiatives in partnership with Global Advocacy teams, ensuring patient perspectives inform strategy.
Contribute to the Investigator‑Sponsored Trial (IST) and collaborative research strategy across tumour types.

Required Knowledge, Skills & Abilities

Strong background in solid tumours, preferably breast cancer and/or HER2‑targeted therapies.
Minimum of 5 years’ experience in Medical Affairs with demonstrated leadership in strategic planning and execution.
Proven ability to shape medical strategies that drive clinical impact and business success.
Experience leading Phase IV studies, ISTs, and Real‑World Evidence initiatives.
Expertise across marketed and pipeline products with strong strategic and operational leadership capabilities.
Ability to influence and operate effectively within complex matrix environments.
Strong understanding of regulatory, commercialization, market access, and reimbursement frameworks.
Exceptional communication skills and leadership presence in high‑growth, fast‑paced settings.
Willingness to travel as required.

Education & Qualifications

Doctoral degree required (MD, PharmD, PhD); MD (or equivalent) strongly preferred.

#LI-Remote

#LI-DM1

Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.

FOR US BASED CANDIDATES ONLY

Jazz Pharmaceuticals, Inc. is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive. For this role, the full and complete base pay range is: $256,000.00 - $384,000.00

Individual compensation paid within this range will depend on many factors, including qualifications, skills, relevant experience, job knowledge, and other pertinent factors. The goal is to ensure fair and competitive compensation aligned with the candidate's expertise and contributions, within the established pay framework and our Total Compensation philosophy. Internal equity considerations will also influence individual base pay decisions. This range will be reviewed on a regular basis.

At Jazz, your base pay is only one part of your total compensation package. The successful candidate may also be eligible for a discretionary annual cash bonus or incentive compensation (depending on the role), in accordance with the terms of the Company's Global Cash Bonus Plan or Incentive Compensation Plan, as well as discretionary equity grants in accordance with Jazz's Long Term Equity Incentive Plan.

The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, 401k retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: https://careers.jazzpharma.com/benefits.html.

Global Medical Director, Breast Cancer/Pan-Tumor